Analyst Price Targets — DCGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 12, 2025 11:42 am | Richard Close | Canaccord Genuity | $1.50 | $1.10 | StreetInsider | DocGo (DCGO) PT Lowered to $1.50 at Canaccord Genuity |
| February 28, 2025 1:47 pm | — | Deutsche Bank | $2.85 | $3.09 | TheFly | DocGo downgraded to Hold from Buy at Deutsche Bank |
| May 9, 2024 6:44 am | Richard Close | Canaccord Genuity | $5.00 | $3.50 | StreetInsider | DocGo (DCGO) PT Lowered to $5 at Canaccord Genuity |
| April 10, 2024 6:58 am | David Grossman | Stifel Nicolaus | $8.00 | $3.17 | StreetInsider | DocGo (DCGO) PT Lowered to $8 at Stifel |
| April 10, 2024 4:58 am | David Larsen | BTIG | $11.00 | $3.85 | StreetInsider | DocGo (DCGO) PT Lowered to $11 at BTIG |
| April 19, 2022 8:52 am | — | Deutsche Bank | $11.00 | $8.11 | Benzinga | Deutsche Bank Initiates Coverage On DocGo with Buy Rating, Announces Price Target of $11 |
Latest News for DCGO
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have earned an average rating of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company.
DocGo (NASDAQ: DCGO - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Analyst Recommendations This is a summary of recent ratings and
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor,…
DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
DocGo Inc. (DCGO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to earnings of $0.04 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DCGO.
U.S. House Trading
No House trades found for DCGO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.